{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:26:41Z","timestamp":1793363201000,"version":"4.5.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","funder":[{"DOI":"10.13039\/100009831","name":"Brin Wojcicki Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009831","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n                    <jats:title>Significance Statement<\/jats:title>\n                    <jats:p>Little population-based data exist about adults with primary nephrotic syndrome and risks of kidney, cardiovascular, and mortality outcomes. In a cohort of 907 adults with nephrologist-confirmed primary nephrotic syndrome attributed to minimal change disease, FSGS, and membranous nephropathy, adjusted rates of ESKD, acute coronary syndrome, heart failure, ischemic stroke, venous thromboembolism, and death were significantly higher than in 89,593 matched adults with no diabetes or known proteinuria. Adults with FSGS had the highest rate of ESKD, followed by adults with membranous nephropathy and adults with minimal change disease. Additional research is needed to understand the mechanisms underlying these excess risks, and population-level identification strategies on the basis of electronic health records should be implemented to identify and optimize personalized care of patients with primary nephrotic syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Little population-based data exist about adults with primary nephrotic syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To evaluate kidney, cardiovascular, and mortality outcomes in adults with primary nephrotic syndrome, we identified adults within an integrated health care delivery system (Kaiser Permanente Northern California) with nephrotic-range proteinuria or diagnosed nephrotic syndrome between 1996 and 2012. Nephrologists reviewed medical records for clinical presentation, laboratory findings, and biopsy results to confirm primary nephrotic syndrome and assigned etiology. We identified a 1:100 time-matched cohort of adults without diabetes, diagnosed nephrotic syndrome, or proteinuria as controls to compare rates of ESKD, cardiovascular outcomes, and death through 2014, using multivariable Cox regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We confirmed 907 patients with primary nephrotic syndrome (655 definite and 252 presumed patients with FSGS [40%], membranous nephropathy [40%], and minimal change disease [20%]). Mean age was 49 years; 43% were women. Adults with primary nephrotic syndrome had higher adjusted rates of ESKD (adjusted hazard ratio [aHR], 19.63; 95% confidence interval [95% CI], 12.76 to 30.20), acute coronary syndrome (aHR, 2.58; 95% CI, 1.89 to 3.52), heart failure (aHR, 3.01; 95% CI, 2.16 to 4.19), ischemic stroke (aHR, 1.80; 95% CI, 1.06 to 3.05), venous thromboembolism (aHR, 2.56; 95% CI, 1.35 to 4.85), and death (aHR, 1.34; 95% CI, 1.09 to 1.64) versus controls. Excess ESKD risk was significantly higher for FSGS and membranous nephropathy than for presumed minimal change disease. The three etiologies of primary nephrotic syndrome did not differ significantly in terms of cardiovascular outcomes and death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Adults with primary nephrotic syndrome experience higher adjusted rates of ESKD, cardiovascular outcomes, and death, with significant variation by underlying etiology in the risk for developing ESKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1681\/asn.2020111583","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T15:35:17Z","timestamp":1624030517000},"page":"2303-2314","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":74,"title":["Primary Nephrotic Syndrome and Risks of ESKD, Cardiovascular Events, and Death: The Kaiser Permanente Nephrotic Syndrome Study"],"prefix":"10.1681","volume":"32","author":[{"given":"Alan S.","family":"Go","sequence":"first","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland, California"},{"name":"Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California"},{"name":"Departments of Epidemiology, Biostatistics and Medicine, University of California, San Francisco, San Francisco, California"},{"name":"Department of Medicine, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thida C.","family":"Tan","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn M.","family":"Chertow","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan D.","family":"Ordonez","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kaiser Permanente East Bay, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjie","family":"Fan","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Law","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kaiser Permanente East Bay, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Yankulin","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kaiser Permanente San Francisco Medical Center, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet M.","family":"Wojcicki","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology, Biostatistics and Medicine, University of California, San Francisco, San Francisco, California"},{"name":"Department of Pediatrics, University of California, San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijie","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kaiser Permanente East Bay, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kaiser Permanente East Bay, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzien","family":"Khoshniat-Rad","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrong","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1115-844X","authenticated-orcid":false,"given":"Rishi V.","family":"Parikh","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"B1-20240826","first-page":"479","article-title":"Diagnosis and management of nephrotic syndrome in adults","volume":"93","author":"Kodner","year":"2016","journal-title":"Am Fam Physician"},{"key":"B2-20240826","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/bmj.39576.709711.80","article-title":"Nephrotic syndrome in adults","volume":"336","author":"Hull","year":"2008","journal-title":"BMJ"},{"key":"B3-20240826","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199804233381707","article-title":"The nephrotic syndrome","volume":"338","author":"Orth","year":"1998","journal-title":"N Engl J Med"},{"key":"B4-20240826","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ekir.2017.11.016","article-title":"NephCure accelerating cures institute: A multidisciplinary consortium to improve care for nephrotic syndrome","volume":"3","author":"Gipson","year":"2017","journal-title":"Kidney Int Rep"},{"key":"B5-20240826","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2215\/CJN.04500511","article-title":"Clinical outcomes and predictors for ESRD and mortality in primary GN","volume":"7","author":"Chou","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B6-20240826","doi-asserted-by":"crossref","first-page":"e0156441","DOI":"10.1371\/journal.pone.0156441","article-title":"The application of digital pathology to improve accuracy in glomerular enumeration in renal biopsies","volume":"11","author":"Rosenberg","year":"2016","journal-title":"PLoS One"},{"key":"B7-20240826","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ki.2012.428","article-title":"Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach","volume":"83","author":"Gadegbeku","year":"2013","journal-title":"Kidney Int"},{"key":"B8-20240826","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.kint.2017.09.028","article-title":"Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment","volume":"93","author":"Hommos","year":"2018","journal-title":"Kidney Int"},{"key":"B9-20240826","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2215\/CJN.10871016","article-title":"Temporal and demographic trends in glomerular disease epidemiology in the Southeastern United States, 1986-2015","volume":"12","author":"O\u2019Shaughnessy","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B10-20240826","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1136\/pgmj.57.671.566","article-title":"Renal vein thrombosis in nephrotic syndrome: A prospective study and review","volume":"57","author":"Chugh","year":"1981","journal-title":"Postgrad Med J"},{"key":"B11-20240826","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0002-9343(80)80006-4","article-title":"The clinical spectrum of renal vein thrombosis: Acute and chronic","volume":"69","author":"Llach","year":"1980","journal-title":"Am J Med"},{"key":"B12-20240826","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ki.1983.28","article-title":"Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: Incidence and significance","volume":"23","author":"Wagoner","year":"1983","journal-title":"Kidney Int"},{"key":"B13-20240826","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0272-6386(97)90485-6","article-title":"Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976-1979 and 1995-1997","volume":"30","author":"Haas","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"B14-20240826","doi-asserted-by":"crossref","first-page":"15","DOI":"10.7812\/TPP\/15-225","article-title":"The Kaiser Permanente Northern California adult member health survey","volume":"20","author":"Gordon","year":"2016","journal-title":"Perm J"},{"key":"B15-20240826","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/ki.2009.289","article-title":"Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease","volume":"76","author":"Lo","year":"2009","journal-title":"Kidney Int"},{"key":"B16-20240826","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCOUTCOMES.108.801654","article-title":"The Cardiovascular Research Network: A new paradigm for cardiovascular quality and outcomes research","volume":"1","author":"Go","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"B17-20240826","first-page":"1049","article-title":"The HMO Research Network Virtual Data Warehouse: A public data model to support collaboration","volume":"2","author":"Ross","year":"2014","journal-title":"EGEMS (Wash DC)"},{"key":"B18-20240826","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/aje\/121.5.754","article-title":"Ascertainment of vital status through the National Death Index and the Social Security Administration","volume":"121","author":"Curb","year":"1985","journal-title":"Am J Epidemiol"},{"key":"B19-20240826","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0272-6386(04)01081-9","article-title":"Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States","volume":"44","author":"Kitiyakara","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B20-20240826","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2215\/CJN.11761116","article-title":"Primary membranous nephropathy","volume":"12","author":"Couser","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B21-20240826","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2215\/CJN.10131011","article-title":"Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease","volume":"7","author":"Kerlin","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B22-20240826","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2006111300","article-title":"Prophylactic anticoagulation in nephrotic syndrome: A clinical conundrum","volume":"18","author":"Glassock","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B23-20240826","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ki.2011.312","article-title":"Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis","volume":"81","author":"Barbour","year":"2012","journal-title":"Kidney Int"},{"key":"B24-20240826","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.amjmed.2007.08.042","article-title":"Venous thromboembolism in patients hospitalized with nephrotic syndrome","volume":"121","author":"Kayali","year":"2008","journal-title":"Am J Med"},{"key":"B25-20240826","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1053\/j.ajkd.2016.10.032","article-title":"The clinical course of minimal change nephrotic syndrome with onset in adulthood or late adolescence: A case series","volume":"69","author":"Maas","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"B26-20240826","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000448628","article-title":"Venous thromboembolism in primary nephrotic syndrome: Is the risk high enough to justify prophylactic anticoagulation?","volume":"135","author":"Rankin","year":"2017","journal-title":"Nephron"},{"key":"B27-20240826","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1148\/radiol.14140121","article-title":"Pulmonary embolism and renal vein thrombosis in patients with nephrotic syndrome: Prospective evaluation of prevalence and risk factors with CT","volume":"273","author":"Zhang","year":"2014","journal-title":"Radiology"},{"key":"B28-20240826","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.kint.2015.12.041","article-title":"Patients with primary membranous nephropathy are at high risk of cardiovascular events","volume":"89","author":"Lee","year":"2016","journal-title":"Kidney Int"},{"key":"B29-20240826","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ki.1993.292","article-title":"The increased risk of coronary heart disease associated with nephrotic syndrome","volume":"44","author":"Ordo\u00f1ez","year":"1993","journal-title":"Kidney Int"},{"key":"B30-20240826","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.107.716951","article-title":"High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study","volume":"117","author":"Mahmoodi","year":"2008","journal-title":"Circulation"},{"key":"B31-20240826","doi-asserted-by":"crossref","first-page":"104322","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104322","article-title":"Nephrotic syndrome is associated with increased risk of ischemic stroke","volume":"28","author":"Huang","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B32-20240826","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.thromres.2005.03.030","article-title":"Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management","volume":"118","author":"Singhal","year":"2006","journal-title":"Thromb Res"},{"key":"B33-20240826","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00467-015-3173-8","article-title":"Platelet abnormalities in nephrotic syndrome","volume":"31","author":"Eneman","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"B34-20240826","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJMcibr1209459","article-title":"Venous thrombosis in the nephrotic syndrome","volume":"368","author":"Loscalzo","year":"2013","journal-title":"N Engl J Med"},{"key":"B35-20240826","doi-asserted-by":"crossref","DOI":"10.7812\/TPP\/19.126","article-title":"Identifying patients with rare disease using electronic health record data: The Kaiser Permanente Southern California membranous nephropathy cohort [published online ahead of print February 7, 2020]","volume":"24","author":"Sun","year":"2020","journal-title":"Perm J"},{"key":"B36-20240826","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.kint.2019.11.037","article-title":"Electronic health records for the diagnosis of rare diseases","volume":"97","author":"Garcelon","year":"2020","journal-title":"Kidney Int"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.2020111583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:30:07Z","timestamp":1786131007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.2020111583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2020111583","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"2020-11-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}